These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30381487)

  • 1. Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.
    Sun W; Kang DS; Zheng A; Liu STH; Broecker F; Simon V; Krammer F; Palese P
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
    Sun W; Kirkpatrick E; Ermler M; Nachbagauer R; Broecker F; Krammer F; Palese P
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex.
    Martínez JL; Lemus N; Lai TY; Mishra M; González-Domínguez I; Puente-Massaguer E; Loganathan M; Francis B; Samanovic MI; Krammer F; Mulligan MJ; Simon V; Palese P; Sun W
    Vaccine; 2024 May; 42(14):3365-3373. PubMed ID: 38627145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
    Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes.
    Chiba S; Kong H; Neumann G; Kawaoka Y
    mBio; 2023 Aug; 14(4):e0062223. PubMed ID: 37466314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
    Shen C; Chen J; Li R; Zhang M; Wang G; Stegalkina S; Zhang L; Chen J; Cao J; Bi X; Anderson SF; Alefantis T; Zhang M; Cai X; Yang K; Zheng Q; Fang M; Yu H; Luo W; Zheng Z; Yuan Q; Zhang J; Wai-Kuo Shih J; Kleanthous H; Chen H; Chen Y; Xia N
    Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies.
    Ferrara F; Del Rosario JMM; da Costa KAS; Kinsley R; Scott S; Fereidouni S; Thompson C; Kellam P; Gilbert S; Carnell G; Temperton N
    Front Immunol; 2021; 12():661379. PubMed ID: 34108964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
    Zost SJ; Wu NC; Hensley SE; Wilson IA
    J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance.
    Liu STH; Behzadi MA; Sun W; Freyn AW; Liu WC; Broecker F; Albrecht RA; Bouvier NM; Simon V; Nachbagauer R; Krammer F; Palese P
    J Clin Invest; 2018 Nov; 128(11):4992-4996. PubMed ID: 30188868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.
    Laursen NS; Friesen RHE; Zhu X; Jongeneelen M; Blokland S; Vermond J; van Eijgen A; Tang C; van Diepen H; Obmolova G; van der Neut Kolfschoten M; Zuijdgeest D; Straetemans R; Hoffman RMB; Nieusma T; Pallesen J; Turner HL; Bernard SM; Ward AB; Luo J; Poon LLM; Tretiakova AP; Wilson JM; Limberis MP; Vogels R; Brandenburg B; Kolkman JA; Wilson IA
    Science; 2018 Nov; 362(6414):598-602. PubMed ID: 30385580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
    Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
    Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.
    Verma N; Dimitrova M; Carter DM; Crevar CJ; Ross TM; Golding H; Khurana S
    J Virol; 2012 May; 86(10):5515-22. PubMed ID: 22379097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G
    Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary dynamic of antigenic residues on influenza B hemagglutinin.
    Suptawiwat O; Ninpan K; Boonarkart C; Ruangrung K; Auewarakul P
    Virology; 2017 Feb; 502():84-96. PubMed ID: 28024225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibodies neutralizing influenza virus A/H1N1pdm09 and seasonal A/H1N1 strains - Distinct Ig gene repertoires with a similar action mechanism.
    Hiroi S; Kuhara M; Kishi Y; Ono KI; Matsuzawa S; Yamamoto N; Komano J
    Immunobiology; 2018 Mar; 223(3):319-326. PubMed ID: 29107382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prevalent Focused Human Antibody Response to the Influenza Virus Hemagglutinin Head Interface.
    McCarthy KR; Lee J; Watanabe A; Kuraoka M; Robinson-McCarthy LR; Georgiou G; Kelsoe G; Harrison SC
    mBio; 2021 Jun; 12(3):e0114421. PubMed ID: 34060327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.